Dr. Ron Weinberger is the Former Exec Director and CEO of Nanosonics' (ASX:NAN), an $2bn market cap healthcare company. He has over 20-years’ experience developing and commercializing medical devices. During his time at Nanosonics, Dr. Weinberger co-developed the company’s platform technology, launched their breakthrough product ‘Trophon’ globally and created a North American sales team to work alongside GE healthcare. He was instrumental in transforming Nanosonics from a research and development company to one of Australia’s leading medical device commercialization success stories. Dr Weinberger is Non-Executive Chairman of Cleanspace (ASX:CSX).
Dr. Ron Weinberger
CEO and Managing Director